Are Direct-to-Consumer Therapies an Opportunity or Challenge for Your Pharmacy Management Software?

Written by

Mark Sasala

Senior Advisor, Business Innovation

Quick Navigation

Specialty pharmacy used to have a predictable engagement cycle where a physician referral kicked off intake, benefits explanation, insurance prior authorization, prescription fulfillment, and ongoing clinical support.

Today, direct-to-consumer (DTC) therapy models are changing how patients start that journey. Patients increasingly enter through telehealth platforms, digital care programs, and manufacturer HUBs (patient support programs), meaning pharmacies may receive a higher share of new-to-therapy patients requiring full intake support upfront and a rapid response.

Telehealth appointments have especially accelerated over the past decade. An American Medical Association report found that physician telehealth use in 2024 was still substantially higher than pre‑pandemic levels, with 71.4% of physicians reporting using telehealth in their practices weekly vs. just 25.1% who reported that in 2018. When more therapy journeys begin digitally, the operational load on specialty pharmacies rises fast.

Filling more prescriptions might be manageable, but scaling operations requires more thought. Your pharmacy management software and prescription management systems must be able to keep pace with the administrative and coordination workload tied to new-to-therapy starts.

GLP-1 prescriptions demonstrate DTC influence on demand

The rise of GLP-1 prescriptions shows how quickly volume can ramp when awareness, access, and digital pathways align.

FAIR Health reports GLP-1 prescription volume to treat overweight/obesity increased 587% from 2019 to 2024. That kind of growth creates opportunity, but it also stresses operational capacity.

But GLP-1s won’t be the only category to behave this way. As DTC therapy models expand, specialty pharmacies’ intake becomes faster and less predictable, requiring teams to absorb surges while protecting speed to therapy and patient experience.

Why pharmacy workflow automation is essential

When more patients enter through digital and consumer-driven pathways, pharmacies are often managing greater upfront complexities:

  • Higher new patient volume (not just ongoing refills)
  • More eligibility and benefit verification
  • Support of multiple payment methods
  • More prior authorization volume and follow-up
  • More coordination across prescribers, payers, and manufacturer HUB workflows
  • Seamless transfer of prescriptions to dispensing partners when needed
  • More drop-off risk if patients don’t get fast clarity on cost and next steps

This is where pharmacy workflow automation becomes the difference between scaling smoothly and drowning in manual work.

Where pharmacy workflows break under DTC-driven pressure

Below are the predictable breaking points when a pharmacy scales into a high-growth therapy area like GLP-1s or other DTC-influenced specialty programs.

1) Prior authorizations become the biggest constraint

GLP-1 medications frequently require prior authorization. When volume doubles or triples, manual PA tracking (spreadsheets, faxes, calls) becomes unsustainable. Teams spend hours chasing statuses instead of moving patients toward therapy.

If you’re evaluating the best pharmacy management software for high volume, look for systems that convert PA work into structured, trackable workflows rather than scattered inbox tasks.

2) Coverage clarity breaks down and patients drop off

Patients coming through DTC channels may not know whether their plan covers the medication or what their out-of-pocket cost will be.

Pharmacies need to surface that information quickly and communicate next steps clearly, whether that’s copay assistance, an alternative therapy, or a cash-pay option. When this is slow or manual, patients can drop off before they ever start treatment.

3) Patient onboarding can’t keep pace

A fast-growing patient population creates simultaneous spikes in intake, data entry, and care coordination.

Without pharmacy workflow automation, each new patient adds linear time to the team’s workload. What used to be manageable at a low volume of new patients a month can become untenable at scale.

4) Generic software forces workarounds (and workarounds don’t scale)

GLP-1 programs have therapy-specific operational requirements: dose schedules, refill cadences, and side-effect monitoring.

When your pharmacy tools aren’t built for therapy-specific workflows, your team creates workarounds. And workarounds don’t scale.

What pharmacy management software must deliver to support DTC therapy models

Pharmacies that scale high-growth therapies successfully are typically operating in platforms built for specialty complexity, like specialty pharmacy software that turns bottlenecks into repeatable, auditable workflows.

Here’s what operational readiness looks like:

  • Automated prior authorization workflows that reduce turnaround time and enable exception-based queues.
  • Real-time eligibility and benefit verification so patients are clear on what’s covered and what options exist. This is especially critical in GLP-1 therapy, where coverage varies widely by plan and indication.
  • Configurable, therapy-specific workflows so you can build processes around how a therapy actually runs (think: onboarding sequences, titration tracking, refill management) without IT projects or manual workarounds.
  • End-to-end visibility across the patient journey so intake, clinical management, billing, and patient communication stay connected in one system and nothing falls through the cracks.

To learn more about Inovalon’s approach, explore ScriptMed specialty pharmacy software.

Don’t let DTC models outpace your systems

GLP-1s are today’s most visible example, but the overarching trend is here to stay: patients are increasingly entering specialty therapy journeys through DTC pathways.

The pharmacies that thrive will be the ones whose pharmacy management software is built to absorb high-volume surges, automate the repetitive work, shorten time to therapy, and keep pharmacists focused on patient care.

Frequently Asked Questions

What is the best pharmacy management software for high volume?

The best pharmacy management software for high volume combines automated prior authorization workflows, real-time eligibility verification, and configurable therapy-specific processes in a single platform. Look for systems that enable exception-based work queues so teams can scale without adding headcount.

What pharmacy software handles prior authorizations?

Modern pharmacy software handles prior authorizations, automates submissions, tracks real-time status, and routes exceptions to staff for follow-up. This reduces manual chasing and helps shrink time-to-therapy, especially in high-PA categories like GLP-1s.

How can pharmacies manage increasing prescription volume without adding headcount?

To manage increasing prescription volume, pharmacies typically need pharmacy workflow automation for intake, benefits verification, PA tracking, and patient outreach. The goal is to reduce manual steps, so growth doesn’t force linear staffing increases.

What pharmacy management software is best for specialty pharmacy?

For specialty operations, look for specialty pharmacy software with therapy-specific configurability, integrated clinical/operational/financial visibility, and the ability to scale during sudden volume spikes driven by DTC therapy models.

What software can help handle GLP-1 prescriptions?

Software to handle GLP-1 prescriptions should support high-volume PA processing, rapid benefits verification, and configurable workflows for titration, refill cadence, and monitoring without forcing manual workarounds.


Inovalon and design® and Inovalon® are trademarks of Inovalon, Inc.